Larry J. Jolivette, Ph.D.

VP, DMPK

20+ years in drug discovery and development of small molecule, biologics and protein degraders. Previous leadership role at GlaxoSmithKline (GSK), primarily in cardiovascular, renal and neuroscience therapeutic areas.